BioPharma Resources

Blog

Guides to free drug and biotech data

How to find, read and use the public databases behind drug research: FDA approvals and labels, adverse event reports, clinical trials, Medicare spending, and the programs that speed drugs to market. Written for clinicians, pharmacists, payers, students and biotech investors.

Guides

Free drug databases: the main ones and what each is for

A guide to the main free drug databases from FDA, NLM and CMS: what Drugs@FDA, DailyMed, the Orange Book, FAERS and others hold, and which to use when.

November 18, 2026 · 6 min read

Guides

How to find every FDA-approved drug for a condition

Find FDA approved drugs for any condition by searching indications on current FDA labels, grouped by drug class, with the limits of the search explained.

November 18, 2026 · 6 min read

Data reports

FDA novel drug approvals in 2026: the full list so far, with trends

Every FDA novel drug approval in 2026 so far: 53 new molecular entities and biologics through November 17, with dates, ingredients, approved uses and trends.

November 18, 2026 · 7 min read

Guides

How to search Drugs@FDA: approval history, labels and letters

How to search Drugs@FDA step by step: find a drug's application, read its approval history, and open approval letters, FDA reviews and every label version.

November 18, 2026 · 6 min read

FDA programs

What is a PDUFA date? How FDA action dates work

What is a PDUFA date? It is FDA's target date to act on a drug or biologic application. How review clocks are set, what moves them and where to find them.

November 18, 2026 · 6 min read

Drug safety

How to search FAERS, FDA's adverse event database

How to search FAERS, the FDA Adverse Event Reporting System: three ways to look up reports for a drug, how to read the counts, and what the data cannot show.

November 18, 2026 · 5 min read

Data reports

FDA-approved GLP-1 drugs list, and what Medicare spends on them

The FDA-approved GLP-1 drugs list with approval dates and companies, plus Medicare Part D GLP-1 spending from 2020 to 2024 and the semaglutide negotiation.

November 18, 2026 · 5 min read

FDA programs

Breakthrough therapy vs fast track: FDA expedited programs compared

Breakthrough therapy vs fast track, accelerated approval and priority review: what each FDA program requires, what it gives, and how often each is used.

November 18, 2026 · 6 min read

Pricing and access

How much does Medicare spend on a drug? Part D and Part B data

Look up Medicare Part D spending by drug and Part B drug spending with free CMS data: what the numbers include, how rebates and ASP work, and how to rank drugs.

November 18, 2026 · 6 min read

Industry research

How to research a biotech pipeline with free public data

A step-by-step method for biotech pipeline research and due diligence using free public data: FDA approvals, ClinicalTrials.gov, SEC filings and PDUFA dates.

November 18, 2026 · 6 min read

Industry research

Free alternatives to paid pharma intelligence databases

Free alternatives to paid pharma intelligence databases: what Drugs@FDA, openFDA, ClinicalTrials.gov, EDGAR, CMS and PubMed cover, and where paid tools help.

November 18, 2026 · 6 min read

Guides

How to find every clinical trial for a drug on ClinicalTrials.gov

How to find clinical trials for a drug on ClinicalTrials.gov: search by intervention, add code names, filter by phase and status, and check other registries.

November 18, 2026 · 6 min read

Guides

Orange Book vs Purple Book: patents, exclusivity and equivalence

Orange Book vs Purple Book explained: which drugs each FDA list covers, how patents, exclusivity and therapeutic equivalence codes work, and how to search both.

November 18, 2026 · 6 min read

FDA programs

NDA vs BLA vs ANDA: FDA application types explained

NDA vs BLA vs ANDA explained: what each FDA application covers, how 505(b)(1), 505(b)(2), 505(j), 351(a) and 351(k) differ, and which exclusivity applies.

November 18, 2026 · 6 min read

FDA programs

Orphan drug designation: what it means and how to find orphan drugs

Orphan drug designation explained: the under-200,000 rule, 7 years of exclusivity, tax credit and fee waiver, and where to look up orphan drugs and approvals.

November 18, 2026 · 6 min read

Drug safety

Proportional reporting ratio (PRR): how drug safety signals are found

The proportional reporting ratio (PRR) compares how often a reaction is reported for one drug against all other drugs. Formula, worked example and limits.

November 18, 2026 · 7 min read

Guides

How to read an FDA drug label (prescribing information)

How to read prescribing information on an FDA drug label, section by section: Highlights, the boxed warning, indications, dosing, warnings and clinical studies.

November 18, 2026 · 6 min read

Pricing and access

Biosimilars and interchangeable biologics, and how to find them

Biosimilar database guide: what biosimilars and interchangeable biosimilars are, how substitution works, and how to find them in FDA's Purple Book for free.

November 18, 2026 · 6 min read

Drug safety

Drug recalls: Class I, II and III explained, and how to look them up

Drug recall lookup: what FDA Class I, II and III recalls mean under 21 CFR 7.3, how market withdrawals differ, and how to search FDA enforcement reports.

November 18, 2026 · 6 min read

Drug safety

How to check whether a drug is in shortage: FDA and ASHP lists

How to check the FDA drug shortage list and other drug shortage databases, what each status means, and why FDA and ASHP counts differ. Free, official sources.

November 18, 2026 · 5 min read